Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Screaming BUY
Shares are getting harder & harder to get on the cheap
Mikros news yesterday(MKRS)Systems Corporation Opens a New Facility in Pinellas County, Florida to Support ADEPT Production and Other Services
Wednesday February 4, 7:00 am ET
PRINCETON, N.J., Feb. 4, 2009 (GLOBE NEWSWIRE) -- Mikros Systems Corporation (OTC BB:MKRS.OB - News), announced today that it has opened a new facility in Pinellas County, FL. The new facility will support production of Mikros' Advanced Diagnostic Electronic Portable Testset (ADEPT) product line and quality assurance, field support, and life cycle management services for both Mikros products and products of other companies. The new facility is located in the Young -- Rainey STAR Center at 8076 114th Ave N., Largo, FL 33777, which is less than 20 miles from the Tampa International Airport and near many of the area's largest defense and homeland security companies.
ADVERTISEMENT
``We are thrilled with the many opportunities this new facility will bring. This facility will provide additional storage and shop space for our growing technical and support staff, and is strategically located in an area of the nation where many growing defense and homeland security companies reside. This is a major step forward in improving our ability to deliver the ADEPT product line to the fleet and provides us with a new platform for business development in this growing region,'' stated Thomas Meaney, President of Mikros.
About Mikros
Mikros Systems Corporation is an advanced technology company specializing in the research and development of electronic systems technology primarily for military applications. Classified by the U.S. Department of Defense as a small business, its capabilities include technology management, electronic systems engineering and integration, radar systems engineering, combat/command, control, communications, computers and intelligence systems engineering, and communications engineering. Mikros' primary business is to pursue and obtain contracts from the Department of Homeland Security, U.S. Navy, and other governmental authorities. For more information on Mikros visit: http://www.mikros.us
The Mikros Systems Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=5815
Important Information about Forward-Looking Statements: All statements in this news release other than statements of historical facts are forward-looking statements which contain our current expectations about our future results. Forward-looking statements involve numerous risks and uncertainties. We have attempted to identify any forward-looking statements by using words such as ``anticipates,'' ``believes,'' ``could,'' ``expects,'' ``intends,'' ``may,'' ``should'' and other similar expressions. Although we believe that the expectations reflected in all of our forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct. Such statements are not guarantees of future performance or events and are subject to known and unknown risks and uncertainties that could cause the Company's actual results, events or financial positions to differ materially from those included within the forward-looking statements. Such factors include, but are not limited to, changes in business conditions, changes in our sales strategy and product development plans, changes in the marketplace, continued services of our executive management team, our limited marketing experience, competition between us and other companies seeking SBIR grants, competitive pricing pressures, market acceptance of our products under development, delays in the development of products, statements of assumption underlying any of the foregoing, and other factors disclosed in our annual report on Form 10-KSB for the year ended December 31, 2007 and other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date hereof.
Contact:
Mikros Systems Corporation
Thomas J. Meaney
(609) 987-1513
Great MKRS news,looks good going forward.I see largo Fl is the hometown of DRS.Buy Buy Buy
Hi swanni,i'll be looking to buy some VODG today on the dip.
Good to see some action on the MKRS website.Thanks
Pfizer to buy Wyeth for $68 billion, cuts dividend
Buzz Up Send
Email IM Share
Digg Facebook Newsvine del.icio.us Reddit StumbleUpon Technorati Yahoo! Bookmarks Print 56 mins ago Reuters – A view of the Belgian headquarters of U.S. pharmaceutical giant Pfizer, in Brussels January 23, 2007. …
Related Quotes Symbol Price Change
^DJI 8,077.56 -45.24
^GSPC 831.95 0.00
^IXIC 1,477.29 0.00
NEW YORK (Reuters) – Pfizer Inc, the No. 1 drugmaker, said on Monday that it would acquire U.S. rival Wyeth for about $68 billion in a move to diversify its revenue base.
The world's largest drugmaker, which raised $22.5 billion in debt from a consortium of banks to finance the deal, also cut its dividend.
The deal helps Pfizer cope with a major gap in revenue in 2011, when its blockbuster Lipitor cholesterol treatment will begin to face U.S. generic competition. Next year, Wyeth loses patent protection on its own top drug, the anti-depressant Effexor XR.
Still, the deal would help Pfizer diversify into vaccines and injectable biologic medicines by adding Wyeth's big-selling Prevnar vaccine for childhood infections and Enbrel rheumatoid arthritis treatment. Pfizer would also realize major cost savings by streamlining areas that overlap.
For each share of Wyeth, Pfizer will pay roughly $50.19 -- $33 in cash and 0.985 of a share of its stock.
Based on Wyeth's 1.33 billion shares outstanding as of October 31, the deal would be valued at about $66.8
Great piece on Stem cell Thanks, 3 Ways That Stem Cells May Speed New Cures
First stem cell trial in humans may be followed by end on federal ban
By Nancy Shute
Posted January 23, 2009
With the first-ever human test of a medical treatment based on embryonic stem cells gaining federal approval, researchers are optimistic that President Obama will soon lift a controversial Bush-administration ban on federal funding for embryonic stem cell research and speed work developing treatments for diabetes, heart disease, cancer, Parkinson's, and Alzheimer's.
Human induced pluripotent stem cells, or iPS cellsRelated News
What Stem Cells Can Do—and Can't
Disease-Specific Stem Cell Lines Developed
New Technique Harvests Stem Cells at Earlier Stage
Beyond Insulin: Searching for a Cure to Type 1 Diabetes
Scientist Grapple with Setback to Stem Cell Research
Will California Become the Nation's Leader in Stem Cell Research?
The Food and Drug Administration today approved human tests of stem cells to repair spinal cord injuries. The first test will involve eight to 10 people with spinal cord injuries below the neck and will start sometime this summer, according to Thomas Okarma, president and CEO of Geron Corp. of Menlo Park, Ca., which developed the stem cell treatment. Patients will be injected seven to 14 days after being injured.
Although this Phase 1 test is intended just to test the safety of the stem cell treatment, the researchers will be looking closely to see if the injected cells bridge the gap in a severed spinal cord, as stem cells have done in mouse studies. Embryonic stem cells have the ability to turn into any type of human tissue cell, which is why researchers are so excited about their potential. The Geron researchers also will assess whether the patients gain any return of sensation, bowel or bladder function, or movement in their legs. "That would be a very exciting finding," Okarma said. If this trial does well, the company expects to expand it to include patients with cervical spinal cord injuries, which are much more common and cause paralysis in all four limbs.
The FDA's approval of the trial three days after Obama took office was coincidental, according to the agency and Geron officials. "We have no evidence that there was any political shadow over this process," Okarma said today. Indeed, the embryonic cells used by Geron come from stem cell lines created before the 2001 Bush administration ban on federal funding for embryonic stem cell research. The ban came about because embryonic stem cells are derived from human embryos that were made for in vitro fertilization but never used. Today's go-ahead raises hopes that either the Obama administration or Congress will soon rescind the ban, which researchers say has hindered their ability to move quickly on developing potential cures.
Scientists are trying to use stem cells in three ways: 1) In the laboratory, to create an infinite variety of living human cells to better test the disease-fighting ability of new drugs in test tubes; 2) As patch kits, with cells injected to repair injured body parts, such as spinal cord or heart muscle cells; 3) To create transplants that could be used to replace body parts.
For instance, Geron is also trying to develop embryonic stem cell treatments for heart disease, in which the injected cells would be used to rebuild damaged heart muscle, and for type 1 diabetes, with the goal being to rebuild islet cells in the pancreas that were destroyed by the patient's immune system. The biotech firm is also investigating making cartilage to repair arthritic joints, bone cells to combat osteoporosis, and liver cells to treat liver failure. Other companies and researchers are pursuing treatments for sickle cell, cystic fibrosis, Parkinson's, Tay-Sachs, leukemia, and Alzheimer's.
Maybe a pr soon per Ding over on R Bull That would be good
I'll be looking to buy VODG & ASTM today Thanks
MKRS connection with ERIC & Homeland security sounds pretty interesting.
Great news for MKRS yesterday,i tried for some @.20 and didn't get any!Maybe today
I had a bid for 3.5k @.22 yesterday & didn't get any MKRS
Happy New Year ALL,Have been adding cheap shares!MKRS in 2009
Every little bit helps!
Looking for more today again,Navy wants MKRS Tech.
My add some more MKRS today!
I've been able to add a few more shares of MKRS at the discount price
Looking for more MKRS today,had order @.41 yesterday but didn't get any!Looks like a steal here
I got 50k of those shares yesterday! Looking for more. Good Luck All
Thanks, new to this stuff
Hi new to the I Hub board,i bought into MKRS a few days ago.Looks like it has a great future this company.Will be looking to add more on any dips! Drew